| 注册
首页|期刊导航|医药导报|托伐普坦在大鼠体内的代谢产物鉴定分析

托伐普坦在大鼠体内的代谢产物鉴定分析

徐国佳 蒋欣 夏滨 斯陆勤 黄建耿 李丹 张永军

医药导报2023,Vol.42Issue(12):1772-1779,8.
医药导报2023,Vol.42Issue(12):1772-1779,8.DOI:10.3870/j.issn.1004-0781.2023.12.005

托伐普坦在大鼠体内的代谢产物鉴定分析

Identification of In Vivo Metabolites of Tolvaptan in Rats

徐国佳 1蒋欣 2夏滨 3斯陆勤 3黄建耿 3李丹 4张永军5

作者信息

  • 1. 石河子大学药学院,石河子 832003||石河子大学第一附属医院药学部,石河子 832008||华中科技大学同济医学院药学院,武汉 430030
  • 2. 华中科技大学同济医学院药学院,武汉 430030||武汉市第一医院药学部,武汉 430022
  • 3. 华中科技大学同济医学院药学院,武汉 430030
  • 4. 北京大学深圳医院药学部,深圳 518000
  • 5. 石河子大学药学院,石河子 832003||石河子大学医学院第三附属医院,石河子 832099
  • 折叠

摘要

Abstract

Objective The metabolites of tolvaptan in rats were identified by ultra-performance liquid chromatography-quadrupole-exactive orbitrap high-resolution mass spectrometry(UFLC-Q-Exactive Orbitrap MS),and the possible metabolic pathways of tolvaptan in rats were discussed.Methods Plasma,urine and fecal samples from rats were collected after a single oral administration of 60 mg·kg-1 tolvaptan solid dispersion solution.The protein in the samples was precipitated with acetonitrile.UFLC-Q-exactive orbitrap MS technology was adopted for the sample analysis and the data were processed by Xcalibur 2.0 software.Results According to the retention time,precise relative molecular mass,characteristic fragment ions and related literature reports of each compound,35 metabolites were identified in rat biological samples.Moreover,23,26 and 30 metabolites in the plasma,urine and feces were identified,respectively.The major metabolic pathways of tolvaptan were identified as hydroxylation,carboxylation,hydrolysis,dehydrogenation,glucuronidation and acetylation.Conclusion Our study confirmed the major metabolites of tolvaptan in rats,enriched the metabolite spectrum of tolvaptan in vivo,and provided an experimental basis for the in-depth study of the pharmacodynamic substance basis of tolvaptan.

关键词

托伐普坦/高分辨质谱/代谢产物

Key words

Tolvaptan/High-resolution mass spectrometry/Metabolites

分类

医药卫生

引用本文复制引用

徐国佳,蒋欣,夏滨,斯陆勤,黄建耿,李丹,张永军..托伐普坦在大鼠体内的代谢产物鉴定分析[J].医药导报,2023,42(12):1772-1779,8.

基金项目

国家自然科学基金资助项目(81302837,81803834) (81302837,81803834)

湖北省科技厅重点研发计划项目(2020BCB045). (2020BCB045)

医药导报

OA北大核心CSTPCD

1004-0781

访问量0
|
下载量0
段落导航相关论文